| The impact of lockdown on pediatric ED visits and hospital admissions during the COVID19 pandemic: a multicenter analysis and review of the literature MD Kruizinga, D Peeters, M van Veen, M van Houten, J Wieringa, ... European journal of pediatrics 180, 2271-2279, 2021 | 178 | 2021 |
| Risk factors, treatment, and immune dysregulation in autoimmune cytopenia after allogeneic hematopoietic stem cell transplantation in pediatric patients MD Kruizinga, MJD van Tol, V Bekker, T Netelenbos, FJ Smiers, ... Biology of Blood and Marrow Transplantation 24 (4), 772-778, 2018 | 67 | 2018 |
| Development of novel, value-based, digital endpoints for clinical trials: a structured approach toward fit-for-purpose validation MD Kruizinga, FE Stuurman, V Exadaktylos, RJ Doll, DT Stephenson, ... Pharmacological Reviews 72 (4), 899-909, 2020 | 41 | 2020 |
| Technical validity and usability of a novel smartphone‐connected spirometry device for pediatric patients with asthma and cystic fibrosis MD Kruizinga, E Essers, FE Stuurman, A Zhuparris, N van Eik, ... Pediatric Pulmonology 55 (9), 2463-2470, 2020 | 24 | 2020 |
| The future of clinical trial design: the transition from hard endpoints to value-based endpoints MD Kruizinga, FE Stuurman, GJ Groeneveld, AF Cohen Concepts and Principles of Pharmacology: 100 Years of the Handbook of …, 2019 | 20 | 2019 |
| Towards remote monitoring in pediatric care and clinical trials—Tolerability, repeatability and reference values of candidate digital endpoints derived from physical activity … MD Kruizinga, N Heide, A Moll, A Zhuparris, Y Yavuz, ML Kam, ... PloS one 16 (1), e0244877, 2021 | 15 | 2021 |
| Pharmacokinetics of intravenous and inhaled salbutamol and tobramycin: An exploratory study to investigate the potential of exhaled breath condensate as a matrix for … MD Kruizinga, WAJ Birkhoff, MJ van Esdonk, NB Klarenbeek, ... British Journal of Clinical Pharmacology 86 (1), 175-181, 2020 | 15 | 2020 |
| Finding suitable clinical endpoints for a potential treatment of a rare genetic disease: the case of ARID1B MD Kruizinga, RGJA Zuiker, E Sali, ML de Kam, RJ Doll, GJ Groeneveld, ... Neurotherapeutics 17 (3), 1300-1310, 2020 | 13 | 2020 |
| Effect of intellivent-asv versus conventional ventilation on ventilation intensity in patients with covid-19 ards—an observational study LA Buiteman-Kruizinga, HE Mkadmi, A Serpa Neto, MD Kruizinga, ... Journal of Clinical Medicine 10 (22), 5409, 2021 | 12 | 2021 |
| Adverse effect of lockdowns during the COVID-19 pandemic: increased incidence of pediatric crisis admissions due to eating disorders and adolescent intoxications JM Kersten, M Van Veen, MA Van Houten, J Wieringa, JG Noordzij, ... European journal of pediatrics 182 (3), 1137-1142, 2023 | 10 | 2023 |
| Saliva as a sampling matrix for therapeutic drug monitoring of gentamicin in neonates: A prospective population pharmacokinetic and simulation study A Samb, M Kruizinga, Y Tallahi, M van Esdonk, W van Heel, G Driessen, ... British journal of clinical pharmacology 88 (4), 1845-1855, 2022 | 10 | 2022 |
| Effect of lockdowns on the epidemiology of pediatric respiratory disease—A retrospective analysis of the 2021 summer epidemic MD Kruizinga, JG Noordzij, MA van Houten, J Wieringa, ... Pediatric Pulmonology 58 (4), 1229-1236, 2023 | 9 | 2023 |
| Development and technical validation of a smartphone‐based pediatric cough detection algorithm MD Kruizinga, A Zhuparris, E Dessing, FJ Krol, AJ Sprij, RJ Doll, ... Pediatric Pulmonology 57 (3), 761-767, 2022 | 9 | 2022 |
| The use of intravenous pentamidine for the prophylaxis of Pneumocystis pneumonia in pediatric patients MD Kruizinga, D Bresters, FJ Smiers, AC Lankester, RGM Bredius Pediatric Blood & Cancer 64 (8), e26453, 2017 | 9 | 2017 |
| Development and technical validation of a smartphone-based cry detection algorithm A ZhuParris, MD Kruizinga, M Gent, E Dessing, V Exadaktylos, RJ Doll, ... Frontiers in pediatrics 9, 651356, 2021 | 8 | 2021 |
| Population pharmacokinetics of clonazepam in saliva and plasma: Steps towards noninvasive pharmacokinetic studies in vulnerable populations MD Kruizinga, RGJA Zuiker, KR Bergmann, AC Egas, AF Cohen, ... British journal of clinical pharmacology 88 (5), 2236-2245, 2022 | 6 | 2022 |
| Theoretical performance of nonlinear mixed-effect models incorporating saliva as an alternative sampling matrix for therapeutic drug monitoring in pediatrics: a simulation study MD Kruizinga, FE Stuurman, GJA Driessen, AF Cohen, KR Bergmann, ... Therapeutic Drug Monitoring 43 (4), 546-554, 2021 | 6 | 2021 |
| Clinical validation of digital biomarkers for paediatric patients with asthma and cystic fibrosis: potential for clinical trials and clinical care MD Kruizinga, E Essers, FE Stuurman, Y Yavuz, ML de Kam, A Zhuparris, ... European Respiratory Journal 59 (6), 2022 | 5 | 2022 |
| Postdischarge recovery after acute pediatric lung disease can be quantified with digital biomarkers MD Kruizinga, A Moll, A Zhuparris, D Ziagkos, FE Stuurman, M Nuijsink, ... Respiration 100 (10), 979-988, 2021 | 5 | 2021 |
| Mitochondrial function, grip strength, and activity are related to recovery of mobility after a total knee arthroplasty MPJ van Diemen, D Ziagkos, MD Kruizinga, MR Bénard, P Lambrechtse, ... Clinical and Translational Science 16 (2), 224-235, 2023 | 2 | 2023 |
